Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

PrestoDoctor

JULY 16, 2019

The DPF changed its name in 2000 when it merged with the Ethan Nadelmann’s Lindesmith Center. Additionally, the group has been at the front lines of criminal justice reform and harm reduction, which includes passing numerous regulations and advocating for safe syringe access for opioid addicts. Americans for Safe Access (ASA).

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

The DPF changed its name in 2000 when it merged with the Ethan Nadelmann’s Lindesmith Center. Additionally, the group has been at the front lines of criminal justice reform and harm reduction, which includes passing numerous regulations and advocating for safe syringe access for opioid addicts. Americans for Safe Access (ASA).

Policy 40

Policy DEA Access Media 40

Cannabis Law Report

SEPTEMBER 19, 2019

Here are three of the most pressing matters that might give Congress absolutely no choice but to surrender to marijuana legalization in the interest of public health and safety. . This leaves room for further growth, which may occur from the recent legalization of smokable flower and continued wide access to dispensaries.”

Vaping 55

Vaping Hemp Education Patients 55

Cannabis Law Report

MARCH 25, 2019

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 18, 2000 , 114 Stat. Preventing marijuana possession or use on federal property. . 2(a), (b)(1), Oct.

Banking 45

Banking Law Marijuana State Laws 45